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The limited ability of articular cartilage to repair after traumatic insult or during arthritic degeneration is widely attributed to the fact that the tissue lacks both innervation and vascularisation. However, comparative studies of articular cartilage repair in load bearing and non-load bearing areas of the joint, in addition to some in vitro studies suggest more strongly that adult articular cartilage has, intrinsically, a reasonable repair potential if not ability. ' The possible reasons for this repair limitation will be discussed below, but it is not always the case and, indeed, there are many reports in the developmental literature of substantial repair and/or regenerative capacity of cartilage. An excellent example is the newt limb which, after amputation, not only regenerates the articular cartilage, but also the entire cohort of lost skeletal elements and in the correct spatial pattern. Whilst mammals do not possess such a regenerative potential, during embryology, there can be a considerable degree of regulation which allows for replacement of lost parts.2 At what point in development is the repair capacity of mammalian cartilage restricted and for what reasons? Repair mechanisms apart, we may also ask what can we learn about degenerative joint disease by studying the developing constituent tissues of a joint? Many of the processes which occur during both pathology and repair, seem to mimic some of those processes which occurred during embryonic development. In the following pages I will consider some of the features which appear common to both osteoarthritic cartilage and developing cartilage. Such features include cell proliferation, elevated matrix synthesis and morphogenesis; taken together, these processes constitute growth and in osteoarthritis this is manifest as osteophyte formation. Before addressing these aspects, it is worth considering the primary components of the development of a cartilaginous element of the appendicular skeleton.
Most work on the early development of the appendicular skeleton has been carried out on the embryonic chick. The chick is easily obtained, is cheap and readily accessible through holes cut in the shell. The incubation period of 21 days also facilitates experimental manipulation. In contrast, uterine development makes experimental manipulation of mammalian embryos very difficult. In addition, because the developing skeleton of the chick limb has been used widely as a model for pattern formation, there is a comprehensive literature on most aspects of early skeletogenesis. Whilst the relative lack of data on mammalian species is inconvenient, it is not restrictive since there is a tendancy for the more fundamental processes in embryology to be conserved across vertebrate classes. Consequently, most of the processes and concepts mentioned below will have been obtained and formulated through studies on the chick embryo, but to our knowledge, most will hold for the mammalian counterpart.
The developing limb grows out from the flank of the embryo as an ectodermal outpushing containing mesenchyme which is derived from the somatopleure. At the tip of the early limb, a specialised thickening of the ectoderm develops which is known as the apical ectodermal ridge (AER).3 This ectodermal specialisation is essential for continued outgrowth through inductive influences and the underlying mesoderm, in turn, maintains the AER. Thus limb outgrowth is dependent on reciprocal ectodermal/mesodermal interactions3 which are required throughout the specification of the entire limb skeleton. 4 5 For some time, the limb mesenchyme appears as a homogeneous population (histologically) fairly evenly distributed throughout the limb.
About 12 hours before overt chondrogenesis (at 4 days of incubation), the presumptive cartilage cells condense to form prechondrogenic condensations which lie in the positions of the future skeletal elements and appear in a proximo-distal sequence. Consequently, the first to form in the leg are the condensations of the femur, tibia/fibula. The nature and significance of the prechondrogenic condensation has been the subject of some interest. Considerable cell/cell contact takes place within the condensation6 with gap junctions subsequently being identified7 and recent work has shown that the cells are able to transfer the dye lucifer yellow.8 Whilst some authors stress the importance of the interactions which occur within the prechondrogenic condensation it is, nevertheless, true that single mesenchymal cells isolated from the very early limb before condensation, can become chondrogenic when maintained under appropriate in vitro conditions.9 Consequently, the condensation process does not appear to be a prerequisite for chondrogenic differentiation, but may well facilitate the process by maintaining the cells in a rounded configuration which favours chondrogenesis.' It is more likely Concomitant with the secretion of type II collagen and aggrecan, the cells assume distinctive orientations (figure). Cells in the centre of the rudiment flatten so that their long axes lie perpendicular to the axis of growth.
Those cells residing at the epiphyseal ends of the rudiment remain rounded. Hypertrophy begins at the centre of the flattened cell zone (at 7 days incubation) which now represents the mid-diaphysis. Thus the three chondrocyte types, rounded, flattened and hypertrophic are established and will remain until the closure of the epiphyseal growth plate. Cell division During early development of the cartilage rudiment, there is widespread division within the epiphyseal cartilage and particularly the rounded chondrocytes. 7 After the formation of the secondary centre of ossification, division becomes restricted to the proliferative cells of the epiphyseal plate, and in the developing articular cartilage, to a band of cells in the basal region adjacent to the subchondral plate and a second band of cells beneath the articular surface as described above.'4 15 18 Interestingly, during development, there is a transition of the main proliferative zone from the rounded cells of the epiphysis to the flattened cells of the epiphyseal plate. We do not know what the cellular basis of this transition is, but in vitro, we know that a flattened morphology favours proliferation. '9 Gradually, as growth ceases, so too does proliferation. [20] [21] [22] In mature normal articular cartilage, there is no chondrocyte division. During degenerative disease including animal models of arthritis and experimentally damaged cartilage, chondrocyte proliferation is re-initiated. 23 29 In human osteoarthritis at the time of arthroplasty, the renewed division appears as cell clusters or chondrones which normally reside in the transitional zone. However, the arthritic lesion by this time is advanced and the surface layers highly fibrillated or lost altogether. In cases of repair due to experimental lesions, such as, whole depth defects into the subcondral plate, then the proliferative response can also occupy the full cartilage depth. 5 In such model systems, however, it appears that surface chondrocyte proliferation or clusters are rare. 30 In full-depth articular cartilage explants maintained in organ culture, proliferation is most common in the basal regions of the cartilage (and near the cut edges) but shown that TGFP2 can lead to chondrocyte modulation in vitro with similar characteristics to dedifferentiation, that is, expression of type I collagen. 43 The effects of IGFs are well documented, and in addition to promoting chondrogenesis through stimulation of matrix secretion, have also been shown to be mitogenic for chondrocytes. 33 Ralphs et al44 showed that during the development of the chick humerus, most chondrocytes stained positively for IGF1 peptide but this distribution became restricted to the hypertrophic cartilage region during later development. Again, there appears to be complex patterns of distribution which are little understood. Most authors concur that there appears to be differential potency between IGF1 and IGF2 depending on the chondrocyte location, species and conditions under which the factors are applied.
In general, FGF promotes chondrocyte proliferation probably in concert with some of the TGFI factors. 33 Unfortunately, we know very little about the distribution of FGF in the developing cartilage. However, in addition to maintaining the proliferative state, FGF also inhibits terminal differentiation, that is, hypertrophy. 45 Consequently, this factor may have a role in the establishment and delineation of the calcified cartilage zone and subchondral plate.
We know much less about the distributions and roles of these growth factors in the regulation of the mature normal tissue and during degenerative disease. However, we do know that the extracellular matrix can act as a pool of bound growth factors which may be released and activated during degeneration. This would appear to be the case for TGF3 since the concentration in the tissue has been calculated to be some ten times that required to elicit a stimulatory response when exogenously applied to explants.46 A variety of matrix components are known to selectively bind growth factors and in vitro experiments suggest that for TGFI, decorin or biglycan may be key players. In the mature articular tissue, it is suggested that whilst TGF3 has the ability to promote synthesis generally, it nevertheless may play more of a regulatory role with IGF1 maintaining aggrecan levels. 47 19 However, in relation to the in vivo situation, the role of mechanical stimulation in the initiation of proliferation needs to be investigated. Nevertheless, the above and other data all suggest that considerable disruption to the tissue architecture accompanies renewed proliferation. An interesting corollary is ageing. During normal ageing, there is a decline in cellularity of the superficial zones54 and, since mitotic figures are not observed, we can assume that cell loss is not compensated for by proliferation. Thus the natural decline in cell numbers in the superficial region during ageing would appear to be insufficient stimulus for a significant proliferative repair response. In contrast, during OA superficial cells are lost and is followed by proliferation of chondrocytes in the deeper tissue. Whether these two events are related, however, remains to be established.
Elevated matrix synthesis and turnover We know very little about the role of the rate of matrix synthesis and turnover either during development or repair. There are obvious intrinsic differences between the two situations. During development, both synthesis and turnover are intimately linked to morphogenesis and growth whereas in repair, elevated synthesis is likely to be related to (in the first instance) supplementation of lost matrix with any morphogenetic consequence a secondary effect. Nevertheless, there are several similarities between the two processes. However, before consideration of these facets it is worth remembering that in discussing repair during osteoarthritis, we mean the initial repair response during the early stages of the disease (and probably preclinical). Those responses which occur during the later stages of the disease progression are impossible to interpret and, in any case, are the final throes of a failed reparative response.
Most of the data which have accrued concerning the quantitative and qualitative changes in matrix composition during early OA has been derived from animal models particularly the dog. It has been shown that there is a significant up-regulation of proteoglycan synthesis55 56 although at the same time increased ezymatic degradation which in concert with mechanical loading leads to overall loss of proteoglycan from the matrix. The newly synthesised proteoglycans have many similarities with those from immature animals in that they have a reduced chondroitin-6/4-sulphate ratio and the glycosaminoglycan chain length is increased. We know a lot less about collagen both in development and in OA. We know again from various animal models that collagen type II synthesis is elevated in early OA.60 61 More recently, it has been shown that type IX collagen, which is covalently linked to the surface of type II fibrils and is thought to control the fibril diameter of type II collagen is not correspondingly upregulated. There appears therefore to be an overall depletion of type IX during early OA. 62 The significance of these observations is not clear, and since we know so little about the roles of the various minor collagen types in development, relevant parallels are impossible to draw. However, we are now beginning to gain better insights using transgenic models which include gene knockout experiments. Very recently, it has been reported that mice which do not express the type IX collagen gene develop normally, appear phenotypically normal but develop osteoarthritis after about six months (Olsen, personal communication). Conversely, mice in which the alpha 1 (II) collagen chain gene is overexpressed develop abnormally thick type II collagen fibrils within the cartilage matrix. Intriguingly, such animals die at birth. 63 More easily appreciated is the contribution of another minor collagen, type X. This collagen has an association with calcification and is produced mainly by hypertrophic chondrocytes. In normal cartilage, it is found in the calcified cartilage zone which intergrates with the sub-chondral plate. From late adolescence it is not detected in articular cartilage at all. 64 However, during OA the calcified tide-mark moves up through the tissue depth with a consequent expression of type X collagen both in the newly calcifying cartilage and in the upper transitional zone. 64 
